Treatment of Hepatocellular Carcinoma with Neoadjuvant Nivolumab Alone Versus in Combination with a CCR2/5 Inhibitor or an Anti-IL-8 Antibody

Alexander J. Rossi, Tahsin M. Khan, Areeba Saif, Thomas U. Marron, Jonathan M. Hernandez

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)30-32
Number of pages3
JournalAnnals of Surgical Oncology
Issue number1
StatePublished - Jan 2022

Cite this